Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Hypertens Res. 2009 Mar;32(3):214-9. doi: 10.1038/hr.2008.37. Epub 2009 Jan 30.
The detrimental effects of cigarette smoking on the kidney in healthy individuals without established renal diseases have not been established. We evaluated the effects of smoking on renal function and proteinuria in 35 288 apparently healthy participants who were not on antihypertensive and/or antidiabetic medication and who had undergone a health examination at the Health Promotion Center, Seoul National University Hospital from 1995 to 2006. Renal function was estimated using the simplified Modification of Diet in Renal Disease Study equation for estimated glomerular filtration rate (eGFR), and proteinuria was determined by the spot urine dipstick test. Adjusted eGFR was higher in current smokers (mean+/-s.e.m., 79.3+/-0.1 ml min(-1)) than in ex-smokers (77.3+/-0.2 ml min(-1), P<0.001) and non-smokers (77.7+/-0.1 ml min(-1), P<0.001). The adjusted eGFR of smokers who smoked >20 cigarettes per day were higher than that of individuals who smoked < or =20 cigarettes per day (P<0.001). In participants with an eGFR of <50 ml min(-1), current smoking (38.3+/-1.9 ml min(-1)) and past smoking (39.5+/-1.9 ml min(-1)) were associated with significantly lower eGFR values than non-smoking (45.1+/-1.2 ml min(-1); P=0.007 and P=0.027, respectively). Current smoking was associated with a higher risk of proteinuria (urine dipstick for albuminuria > or =1+) than non-smoking (odds ratio=1.380, P<0.001). In conclusion, cigarette smoking is associated with a higher eGFR in the general population, whereas it might reduce eGFR in a small subset of the population and increase the risk of proteinuria. These subsets should be better defined to prevent chronic kidney diseases related to smoking in the general population.
在没有既定肾脏疾病的健康个体中,吸烟对肾脏的有害影响尚未确定。我们评估了吸烟对 35288 名未服用抗高血压和/或抗糖尿病药物且在 1995 年至 2006 年间在首尔国立大学医院健康促进中心接受健康检查的健康个体的肾功能和蛋白尿的影响。肾功能使用简化的肾脏病饮食改良研究方程估计肾小球滤过率(eGFR),蛋白尿通过尿点试纸试验确定。当前吸烟者的调整后 eGFR 较高(平均值+/-标准误,79.3+/-0.1 ml min(-1)),高于前吸烟者(77.3+/-0.2 ml min(-1),P<0.001)和不吸烟者(77.7+/-0.1 ml min(-1),P<0.001)。每天吸烟>20 支的吸烟者的调整后 eGFR 高于每天吸烟<=20 支的个体(P<0.001)。在 eGFR<50 ml min(-1)的参与者中,当前吸烟(38.3+/-1.9 ml min(-1))和过去吸烟(39.5+/-1.9 ml min(-1))与 eGFR 值明显低于不吸烟(45.1+/-1.2 ml min(-1);P=0.007 和 P=0.027)。当前吸烟与蛋白尿(尿白蛋白试纸试验阳性>或=1+)的风险高于不吸烟(比值比=1.380,P<0.001)。总之,吸烟与普通人群中较高的 eGFR 相关,而在一小部分人群中可能会降低 eGFR,并增加蛋白尿的风险。应更好地定义这些亚组,以防止普通人群中与吸烟相关的慢性肾脏病。